Related Experiment Video
Updated: Dec 18, 2025
08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
113.3K
Wnt Signaling in Gynecologic Malignancies
Alexandra McMellen1, Elizabeth R Woodruff1, Bradley R Corr2,3
1Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, CO 80045, USA.
International Journal of Molecular Sciences
|June 21, 2020
Summary
Wnt/β-catenin signaling is crucial in gynecologic cancers like ovarian and cervical cancer. Targeting this pathway offers potential for new treatments and improved patient outcomes in women's cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gynecologic malignancies, including ovarian, endometrial, and cervical cancers, are a significant global health concern.
- The Wnt/β-catenin signaling pathway is implicated in the development and progression of various cancers.
- Understanding the role of Wnt signaling in gynecologic cancers is vital for therapeutic advancements.
Purpose of the Study:
- To review the evidence linking Wnt/β-catenin signaling to gynecologic malignancies.
- To highlight the role of this pathway in tumorigenesis, metastasis, and treatment resistance.
- To explore the potential of targeting Wnt/β-catenin signaling for novel cancer therapies.
Main Methods:
- Literature review of studies on Wnt signaling in gynecologic cancers.
- Analysis of the role of Wnt/β-catenin in cancer development and progression.
- Examination of therapeutic strategies targeting the Wnt pathway.
Main Results:
- Wnt/β-catenin signaling is a key driver in the initiation and advancement of gynecologic cancers.
- Aberrant Wnt signaling contributes to metastasis and resistance to chemotherapy.
- The pathway's involvement spans ovarian, endometrial, and cervical cancer development.
Conclusions:
- The Wnt/β-catenin pathway is a critical factor in gynecologic oncogenesis.
- Targeting Wnt/β-catenin signaling presents a promising therapeutic avenue for improving patient outcomes.
- Further research into Wnt pathway inhibitors is warranted for effective gynecologic cancer treatment.
Related Concept Videos
02:54Canonical Wnt Signaling Pathway
10.2K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K
01:41Non-Canonical Wnt Signaling Pathways
8.1K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
01:24Disorders of the Female Reproductive System
3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K